In high-risk patients, the TIME consists of abundant B memory cells, cancer-associated fibroblasts (CAFs), endothelial cells, and macrophages, which supports tumor growth; whereas low-risk patients showed more M0 macrophages, activated and memory CD4+ T cells, naive CD8+ T cells, which have a strong effect on tumor cell killing. This evidence concerns the gene CD8A and cancer.